High-resolution diffusion tensor imaging in the substantia nigra of de novo Parkinson disease
- PMID: 19129507
- PMCID: PMC2677508
- DOI: 10.1212/01.wnl.0000340982.01727.6e
High-resolution diffusion tensor imaging in the substantia nigra of de novo Parkinson disease
Erratum in
- Neurology. 2009 Jun 9;72(23):2059
Abstract
Background: In the midbrain of patients with Parkinson disease (PD), there is a selective loss of dopaminergic neurons in the ventrolateral and caudal substantia nigra (SN). In a mouse model of PD, investigators have administered 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and found that measures derived using diffusion tensor imaging (DTI) were correlated with the number of dopamine neurons lost following intoxication.
Methods: Twenty-eight subjects (14 with early stage, untreated PD and 14 age- and gender-matched controls) were studied with a high-resolution DTI protocol at 3 Tesla using an eight-channel phase array coil and parallel imaging to study specific segments of degeneration in the SN. Regions of interest were drawn in the rostral, middle, and caudal SN by two blinded and independent raters.
Results: Fractional anisotropy (FA) was reduced in the SN of subjects with PD compared with controls (p < 0.001). Post hoc analysis identified that reduced FA for patients with PD was greater in the caudal compared with the rostral region of interest (p < 0.00001). A receiver operator characteristic analysis in the caudal SN revealed that sensitivity and specificity were 100% for distinguishing patients with PD from healthy subjects. Findings were consistent across both raters.
Conclusions: These findings provide evidence that high resolution diffusion tensor imaging in the substantia nigra distinguishes early stage, de novo patients with Parkinson disease (PD) from healthy individuals on a patient by patient basis and has the potential to serve as a noninvasive early biomarker for PD.
Figures



Comment in
-
A new sensitive imaging biomarker for Parkinson disease?Neurology. 2009 Apr 21;72(16):1374-5. doi: 10.1212/01.wnl.0000343512.36654.41. Epub 2009 Jan 7. Neurology. 2009. PMID: 19129504 No abstract available.
Similar articles
-
High-resolution diffusion tensor-imaging indicates asymmetric microstructural disorganization within substantia nigra in early Parkinson's disease.J Clin Neurosci. 2018 Apr;50:199-202. doi: 10.1016/j.jocn.2018.01.023. Epub 2018 Feb 1. J Clin Neurosci. 2018. PMID: 29366621
-
Asymmetrical diffusion tensor imaging indices of the rostral substantia nigra in Parkinson's disease.Parkinsonism Relat Disord. 2012 Nov;18(9):1029-33. doi: 10.1016/j.parkreldis.2012.05.021. Epub 2012 Jun 16. Parkinsonism Relat Disord. 2012. PMID: 22705126
-
Quantitative diffusion tensor imaging detects dopaminergic neuronal degeneration in a murine model of Parkinson's disease.Neurobiol Dis. 2007 Jun;26(3):590-6. doi: 10.1016/j.nbd.2007.02.010. Epub 2007 Mar 6. Neurobiol Dis. 2007. PMID: 17428671 Free PMC article.
-
The role of diffusion tensor imaging and fractional anisotropy in the evaluation of patients with idiopathic normal pressure hydrocephalus: a literature review.Neurosurg Focus. 2016 Sep;41(3):E12. doi: 10.3171/2016.6.FOCUS16192. Neurosurg Focus. 2016. PMID: 27581308 Review.
-
Multimodal brain and retinal imaging of dopaminergic degeneration in Parkinson disease.Nat Rev Neurol. 2022 Apr;18(4):203-220. doi: 10.1038/s41582-022-00618-9. Epub 2022 Feb 17. Nat Rev Neurol. 2022. PMID: 35177849 Review.
Cited by
-
The Role of Magnetic Resonance Imaging for the Diagnosis of Atypical Parkinsonism.Front Neurol. 2020 Jul 17;11:665. doi: 10.3389/fneur.2020.00665. eCollection 2020. Front Neurol. 2020. PMID: 32765399 Free PMC article. Review.
-
Increased iron in the substantia nigra pars compacta identifies patients with early Parkinson'sdisease: A 3T and 7T MRI study.Neuroimage Clin. 2024;41:103577. doi: 10.1016/j.nicl.2024.103577. Epub 2024 Feb 17. Neuroimage Clin. 2024. PMID: 38377722 Free PMC article.
-
Investigation of Apparent Diffusion Coefficient from Ultra-high b-Values in Parkinson's Disease.Eur Radiol. 2015 Sep;25(9):2593-600. doi: 10.1007/s00330-015-3678-3. Epub 2015 Mar 7. Eur Radiol. 2015. PMID: 25749787
-
Signal alterations of the basal ganglia in the differential diagnosis of Parkinson's disease: a retrospective case-controlled MRI data bank analysis.BMC Neurol. 2012 Dec 29;12:163. doi: 10.1186/1471-2377-12-163. BMC Neurol. 2012. PMID: 23273141 Free PMC article.
-
Individual voxel-based subtype prediction can differentiate progressive supranuclear palsy from idiopathic Parkinson syndrome and healthy controls.Hum Brain Mapp. 2011 Nov;32(11):1905-15. doi: 10.1002/hbm.21161. Epub 2011 Jan 18. Hum Brain Mapp. 2011. PMID: 21246668 Free PMC article.
References
-
- Hodaie M, Neimat JS, Lozano AM. The dopaminergic nigrostriatal system and Parkinson’s disease: molecular events in development, disease, and cell death, and new therapeutic strategies. Neurosurgery 2007;60:17–28; discussion 28–30. - PubMed
-
- Braak H, Del Tredici K, Rub U, de Vos RA, Jansen Steur EN, Braak E. Staging of brain pathology related to sporadic Parkinson’s disease. Neurobiol Aging 2003;24:197–211. - PubMed
-
- Fearnley JM, Lees AJ. Ageing and Parkinson’s disease: substantia nigra regional selectivity. Brain 1991;114:2283–2301. - PubMed
-
- Martin WR, Wieler M, Gee M. Midbrain iron content in early Parkinson disease: a potential biomarker of disease status. Neurology 2008;70:1411–1417. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical